ProfileGDS5678 / 1439669_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 17% 13% 13% 11% 11% 15% 12% 12% 12% 12% 12% 11% 12% 12% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.4326517
GSM967853U87-EV human glioblastoma xenograft - Control 22.3119713
GSM967854U87-EV human glioblastoma xenograft - Control 32.3132313
GSM967855U87-EV human glioblastoma xenograft - Control 42.2211211
GSM967856U87-EV human glioblastoma xenograft - Control 52.2307611
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.4197215
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.319112
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.2894512
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.2846412
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.2993812
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.2981912
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.2508711
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.2979412
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.3028712